日本関節病学会誌
Online ISSN : 1884-9067
Print ISSN : 1883-2873
ISSN-L : 1883-2873
症例報告
生物学的製剤投与中にListeria菌による人工膝関節周囲感染をきたした1例
雪澤 洋平熊谷 研稲葉 裕松尾 光佑針金 健吾草山 善洋久保田 聡村松 俊太郎長岡 亜紀子齋藤 知行
著者情報
ジャーナル フリー

2014 年 33 巻 1 号 p. 85-89

詳細
抄録
We report the case of a patient with rheumatoid arthritis who developed Listeria monocytogenes septic arthritis affecting her total knee arthroplasty during treatment with etanercept. The patient was a 66-year-old female who had suffered from rheumatoid arthritis for 18 years and was treated with etanercept, methotrexate, and prednisolone. After five days from the last etanercept injection, there was acute painful swelling of her left knee joint. In view of hypotension and high fever she was treated for suspected septic shock with intravenous ampicillin 8 grams total daily dose and fluid resuscitation. About 100 ml of moderately cloudy inflammatory synovial fluid was aspirated and Listeria monocytogenes sensitive to ampicillin was grown on culture. After recovery, all prostheses of the left knee were removed, and cement spacers containing vancomycin were inserted. Several hydroxyapatite blocks containing vancomycin were embedded in the cement spacers to maintain sustained-release of the antibiotic. After 3 months from the implant removal, a revision of total knee arthroplasty was performed. During the operation, no infection was identified by means of intraoperative real-time polymerase chain reaction (PCR) and subsequent histopathology findings. The patient recovered and regained mobility on her left knee joint. No infectious symptoms were observed at 1 year after revision of the total knee arthroplasty.
著者関連情報
© 2014 日本関節病学会
前の記事
feedback
Top